A small remde­sivir study with lots of short­com­ings sug­gests it may be work­ing against Covid-19 — and 1 an­a­lyst fore­casts mid-May roll­out

In a small study in­volv­ing 53 com­pas­sion­ate use cas­es of se­vere­ly af­flict­ed Covid-19 pa­tients, Gilead found en­cour­ag­ing ev­i­dence that sug­gests remde­sivir might be pro­vid­ing a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER